Colorado lawmakers consider ibogaine research bill as experts and advocates debate potential and risks
Updated
Updated · CBS New York · Apr 24
Colorado lawmakers consider ibogaine research bill as experts and advocates debate potential and risks
5 articles · Updated · CBS New York · Apr 24
House Bill 26-1325 would launch a pilot program to study Ibogaine for mental health and substance use, supported by $50 million in new federal funds after President Trump's recent initiative.
Advocates like Adam Vibe Gunton cite personal recovery stories, while experts warn of serious cardiac risks and stress the need for medical oversight and further research due to lack of clinical trials.
Ibogaine was decriminalized under Colorado's Natural Medicine Act, but experts emphasize existing, well-researched opioid treatments and caution against recreational use as lawmakers and stakeholders weigh the drug's future in the state.
Can the FDA responsibly fast-track ibogaine without robust, long-term clinical trial data?
Is ibogaine's 'reset' a miracle cure, or are daily treatments like Suboxone a safer bet?
Could this psychedelic be the breakthrough treatment for veterans suffering from PTSD and TBI?
With known fatal heart risks, how can clinics guarantee patient safety during ibogaine treatment?
As ibogaine goes mainstream, how will its African Indigenous stewards be properly compensated?
Could the global demand for ibogaine drive its native African plant to extinction?